Recursion Pharmaceuticals (RXRX) EBIT (2020 - 2026)
Recursion Pharmaceuticals (RXRX) recorded EBIT of -$134.97 million in Q2 2026, compared with -$176.23 million a year earlier.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) EBIT (2020 - 2026) Analysis & Trends
On a TTM basis, Recursion Pharmaceuticals' EBIT came in at -$544.01 million as of Jun 30, 2026; for FY2025, it came in at -$648.13 million.
- Across earlier years, EBIT came in at -$479 million in FY2024, -$350.06 million in FY2023, -$245.73 million in FY2022 and -$182.78 million in FY2021.
- Quarterly EBIT has ranged from -$191.37 million in Q1 2025 to -$46.4 million in Q3 2021 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$128.51 million (Q1 2026), -$108.33 million (Q4 2025) and -$172.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,145.25 Bn | 1,113.84 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.54 Bn | 542.07 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 511.36 Bn | 484.47 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 366.62 Bn | 321.00 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.46 Bn | 261.45 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.61 Bn | 235.29 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 235.29 Bn | 190.69 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 193.89 Bn | 168.09 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.02 Bn | 118.67 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Recursion Pharmaceuticals | 1.94 Bn | -665.24 Mn | -3.82 Mn | -134.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -134.97 Mn |
| Mar 31, 2026 | -128.51 Mn |
| Dec 31, 2025 | -108.33 Mn |
| Sep 30, 2025 | -172.20 Mn |
| Jun 30, 2025 | -176.23 Mn |
| Mar 31, 2025 | -191.37 Mn |
| Dec 31, 2024 | -183.77 Mn |
| Sep 30, 2024 | -98.35 Mn |
| Jun 30, 2024 | -100.54 Mn |
| Mar 31, 2024 | -96.34 Mn |
| Dec 31, 2023 | -98.93 Mn |
| Sep 30, 2023 | -99.55 Mn |
| Jun 30, 2023 | -81.72 Mn |
| Mar 31, 2023 | -69.87 Mn |
| Dec 31, 2022 | -60.98 Mn |
| Sep 30, 2022 | -62.57 Mn |
| Jun 30, 2022 | -66.19 Mn |
| Mar 31, 2022 | -55.98 Mn |
| Dec 31, 2021 | -64.96 Mn |
| Sep 30, 2021 | -46.40 Mn |
API Access
Recursion Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();